Table 1 Baseline characteristics of included patients with different pathological types

n

396

34

106

34

Age, mean ± sd

54.705 ± 8.7763

64.088 ± 9.0833

61.453 ± 8.5213

58 ± 5.1757

 < 0.001

 < 0.001

 < 0.001

0.002

Menopause, n (%)

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 Yes

235 (59.3%)

31 (91.2%)

95 (89.6%)

32 (94.1%)

 No

150 (37.9%)

3 (8.8%)

10 (9.4%)

2 (5.9%)

 Unknown

11 (2.8%)

0 (0%)

1 (0.9%)

0 (0%)

 BMI, median (IQR)

25.462 (23.422, 28.134)

26.531 (22.481, 28.125)

24.654 (22.638, 27.447)

25.1 (23.508, 26.667)

0.480

0.933

0.162

0.430

Stage, n (%)

 < 0.001

 < 0.001

 < 0.001

 < 0.627

 IV

2 (0.5%)

1 (2.9%)

11 (10.4%)

0 (0%)

 III

27 (6.8%)

6 (17.6%)

26 (24.5%)

4 (11.8%)

 II

6 (1.5%)

2 (5.9%)

7 (6.6%)

1 (2.9%)

 I

361 (91.2%)

21 (61.8%)

59 (55.7%)

29 (85.3%)

 Unknown

0 (0%)

4 (11.8%)

3 (2.8%)

0 (0%)

Myometrial infiltration (> = 1/2), n (%)

 < 0.001

0.090

 < 0.001

0.182

 Yes

70 (17.7%)

4 (11.8%)

49 (46.2%)

10 (29.4%)

 No

297 (75%)

24 (70.6%)

50 (47.2%)

23 (67.6%)

 Unknown

29 (7.3%)

6 (17.6%)

7 (6.6%)

1 (2.9%)

Cervix involvement, n (%)

 < 0.001

0.142

 < 0.001

0.073

 Yes

18 (4.5%)

4 (11.8%)

23 (21.7%)

3 (8.8%)

 No

333 (84.1%)

25 (73.5%)

80 (75.5%)

31 (91.2%)

 Unknown

45 (11.4%)

5 (14.7%)

3 (2.8%)

0 (0%)

Lymph node metastasis, n (%)

 < 0.001

0.008

 < 0.001

0.053

 Yes

19 (4.8%)

6 (17.6%)

31 (29.2%)

2 (5.9%)

 No

299 (75.5%)

23 (67.6%)

62 (58.5%)

31 (91.2%)

 Unknown

78 (19.7%)

5 (14.7%)

13 (12.3%)

1 (2.9%)